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Na’,K+-ATPase (NKA) is a major determinant of 
excitation/contraction where inhibition of NKA with 
glycosides such as digitalis improve inotropic state. 
Optimal glycoside therapy depends upon an intact NM 
system, however changes in NKA activity and glycoside 
receptor density with the development of cardiomyopathy are 
not defined. Accordingly, LV function and HKA activity, 
glycoside binding, and immunolocation were examined in 7 
casdiomyopathic pigs produced by atria1 pacing for 3 weeks 
(SVT;24Obpm) and 7 controls. Fractional shortening(FS), 
diastolic dimension(EDD), pressure(EDP), and stress(EDo) 
were computed by echo/catheterization. 
(.p<O. OS) 
Control 31+3 3.510.2 1,723 69 
SVT 1523” 5.1+,0.2” 12026” 22+4* 
NKA activity was assayed as potassium p-nitro-phenol- 
phosphatase (kg pNF/mg/hr) . iiaximuin m.unbcr oi giycoside 
receptors (Bmax) and affinity (Kd) were determined from ‘H- 
ouabain binding assays. 
4c~1vm @max a Kd(nM1 
Control 0.6420.06 5.520.4 15.323.4 
SWT 0.45f0.12* 1.9+0.4’ 8.8+_2.6* 
Immunohistochemistry revealed a reduction in sarcolemmal 
NKA content in SVT sections. Thus a potential mechanism 
for reduced NKA activity and glycoside receptor density is 
decreasedmyocyte NKAconcentration. Altered N’KA glycoside 
receptor density and affinity may attenuate the 
effectiveness of cardiac glycoside therapy in SVT induced 
cardiomyopathy. These changes in NKA activity and 
glycoside responsiveness may have important implications 
in the treatment of dilated cardiomyopathies. 
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Abnormal Ca” homeostasis may underlie 
myocardial dysfunction in end-stag$+heart 
disease. Calmodulin (CAL) is a Ca - 
binding protein that plays a major role in 
cell regulatiovp To further understand 
the role of Ca in+Qeart diseaser we 
measured CAL and Ca in the left 
ventricle of hearts from normal donors 
(controls, 6) and transplant patients with 
idiopathic dilated cardiomyopathy (IDCo 
6), ischemic heart disease (IBDo 6) and 
valve disease (4). 
Cant rol IDC H . 
CA$Tb 9::“” 49;$:22’= 4;;&;S” 
Ca 1 1 
mean + SD; a ng/mg protein; b umol/gm dry 
wt; c PcO.01; d P(O.05. 
Increases in C and Ca++ support the 
concept that calcium regulatory function 
is lost in end-stage myocardial disease. 
Although these changes may be compensatory 
in response to increased calcium influx 
into the myocyter loss of calmodulin- 
mediated cell regulation may promote 
progression of myocardial dysfunction and 
could account for secondary degenerative 
changes in the heart. 
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Altered myocalrdial bioenergeti 
paehogenesis 00: congestive hea 
may play a role in the 
failure. 
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The rapid 
mode has been shown to have 
hemodynamic, neurohumoral and mechanical abnormalities 
similar to dilated cardiomyopathy in humans. To evaluate 
of this model, 8 acute 
after pacing at 
g P31 NBisR spectroscopy 
17 days. The hearts 
Creatine phosqnate 
e (Pi) were assessed via 
stole. Hearts were 
nd during increased 
beats/min; AP), dobuta- 
seline mean LVEDP was 
20, increased to 34 during AP a decreased to 8 during 
D, Whole wall CP/ATP ratio at post-pacing baseline was 
control dogs: 2.012.08 vs. 
arts with failure, endocardial 
ith AP from 2.11k.14 to 1.84+.19. 
cted at base1 in@ in some 
alities accompany the marked 
s in this model of congestive 
heart failure. This is reflected by the decrease in the 
CP/ATP ratio which is further reduced during the stress 
of acute pacing and the presence of Pi. 
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The effect of myocardial a-adrenergic receptor st 
icular diaslolic performance in man is unknown 
&2 invesiigalions suggest t a-adrenergic stimulalion 
rate of myocardial relaxation. is investigation examined the effect 
of acute stimulation and blockade of myocardial a-adrenergic 
receptors on the rate of isovolumic relaxation in the failing and non - 
an left ventricle. 
and nhentolamine 
normal LV function (MS) and 7 pts with 
ylephrine (PHP, final concentration 10 uM) 
0.2 m&min) were infused inlo the left main 
PHP had no effect on LV diastoli 
effects of the a- and 
er, selective a-adren 
adrenergic reCeptora. 
